{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:02:13Z","timestamp":1778166133094,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T00:00:00Z","timestamp":1664668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery: X"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.wnsx.2022.100148","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:24:52Z","timestamp":1665552292000},"page":"100148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-9372","authenticated-orcid":false,"given":"Yohannes","family":"Ghenbot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-4472","authenticated-orcid":false,"given":"John D.","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"Wathen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monisha A.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wnsx.2022.100148_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.wnsx.2022.100148_bib2","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2015.4369","article-title":"Stroke prevention in atrial fibrillation: a systematic review","volume":"313","author":"Lip","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.wnsx.2022.100148_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1089\/neu.2011.2197","article-title":"Epidemiological shifts in elderly traumatic brain injury: 18-year trends in Pennsylvania","volume":"29","author":"Ramanathan","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wnsx.2022.100148_bib4","first-page":"552","article-title":"Predicting mortality in traumatic intracranial hemorrhage","volume":"132","author":"Powers","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wnsx.2022.100148_bib5","doi-asserted-by":"crossref","first-page":"e0191137","DOI":"10.1371\/journal.pone.0191137","article-title":"Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: global survey of the practices of neurologists, neurosurgeons and thrombosis experts","volume":"13","author":"Xu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.wnsx.2022.100148_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.wnsx.2022.100148_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamacardio.2021.3702","article-title":"Temporal association between episodes of atrial fibrillation and risk of ischemic stroke","volume":"6","author":"Singer","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.wnsx.2022.100148_bib8","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.wneu.2021.02.135","article-title":"Timing of restarting anticoagulation and antiplatelet therapies after traumatic subdural hematoma\u2014a single institution experience","volume":"150","author":"Naylor","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wnsx.2022.100148_bib9","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","volume":"129","author":"Sherwood","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.wnsx.2022.100148_bib10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archneur.57.12.1710","article-title":"Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk","volume":"57","author":"Phan","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wnsx.2022.100148_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archneur.65.10.1313","article-title":"Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage","volume":"65","author":"Claassen","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.wnsx.2022.100148_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/CPJ.0000000000000425","article-title":"Anticoagulation for atrial fibrillation after intracranial hemorrhage: a systematic review","volume":"8","author":"Hawkes","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.wnsx.2022.100148_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.wnsx.2022.100148_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.wnsx.2022.100148_bib15","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/STROKEAHA.115.009087","article-title":"Antithrombotic treatment following intracerebral hemorrhage in patients with and without atrial fibrillation","volume":"46","author":"Pennlert","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2022.100148_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.wnsx.2022.100148_bib17","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.wneu.2018.10.173","article-title":"Use of anticoagulation agents after traumatic intracranial hemorrhage","volume":"123","author":"Divito","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wnsx.2022.100148_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1749-7922-7-25","article-title":"Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage","volume":"7","author":"Byrnes","year":"2012","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.wnsx.2022.100148_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/STROKEAHA.114.007199","article-title":"Stroke and major bleeding risk in elderly patients aged \u226575 years with atrial fibrillation: the Loire Valley atrial fibrillation project","volume":"46","author":"Lip","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2022.100148_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40266-021-00870-6","article-title":"Impact of fall risk and direct oral anticoagulant treatment on quality-adjusted life-years in older adults with atrial fibrillation: a Markov decision analysis","volume":"38","author":"Wei","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.wnsx.2022.100148_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib22","doi-asserted-by":"crossref","first-page":"e000605","DOI":"10.1136\/tsaco-2020-000605","article-title":"Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials","volume":"5","author":"King","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"key":"10.1016\/j.wnsx.2022.100148_bib23","series-title":"Direct Oral Anticoagulants from Pharmacology to Clinical Practice","author":"Proietti","year":"2021"},{"key":"10.1016\/j.wnsx.2022.100148_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal\u2014full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa1510991","article-title":"Andexanet\u00a0alfa for the reversal of factor Xa inhibitor activity","volume":"373","author":"Siegal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib26","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.110.004424","article-title":"Dabigatran etexilate: a new oral thrombin inhibitor","volume":"123","author":"Hankey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.wnsx.2022.100148_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2125.2012.04369.x","article-title":"Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects","volume":"75","author":"Frost","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.wnsx.2022.100148_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.wnsx.2022.100148_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40262-015-0342-7","article-title":"Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin k antagonist oral anticoagulant that inhibits clotting factor Xa","volume":"55","author":"Parasrampuria","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.wnsx.2022.100148_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet\u00a0alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib31","first-page":"2499","article-title":"Andexanet\u00a0alfa for factor Xa inhibitor reversal","volume":"375","author":"Connolly","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2015.07.001","article-title":"Risk of venous thromboembolism after receiving prothrombin complex concentrate for warfarin-associated intracranial hemorrhage","volume":"50","author":"Felton","year":"2016","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5811\/westjem.2019.4.41649","article-title":"Thromboembolic risk of 4-factor prothrombin complex concentrate versus fresh frozen plasma for urgent warfarin reversal in the emergency department","volume":"20","author":"Maguire","year":"2019","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.wnsx.2022.100148_bib34","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/STROKEAHA.112.650614","article-title":"Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial","volume":"43","author":"Hart","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2022.100148_bib35","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2016-08-731638","article-title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy","volume":"129","author":"Lopes","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.wnsx.2022.100148_bib36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2022.100148_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.wnsx.2022.100148_bib41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/STROKEAHA.118.023797","article-title":"Non-vitamin k antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with intracerebral hemorrhage","volume":"50","author":"Nielsen","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2022.100148_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/WNL.0000000000002310","article-title":"Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type","volume":"86","author":"Wilson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.wnsx.2022.100148_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12028-019-00912-3","article-title":"Are direct anticoagulants safer in traumatic brain injury compared to warfarin?","volume":"32","author":"Wartenberg","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wnsx.2022.100148_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3171\/2019.4.JNS19252","article-title":"Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes","volume":"133","author":"Scotti","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wnsx.2022.100148_bib45","doi-asserted-by":"crossref","first-page":"108983","DOI":"10.1155\/2012\/108983","article-title":"Stroke prevention in atrial fibrillation: understanding the new oral anticoagulants dabigatran, rivaroxaban, and apixaban","volume":"2012","author":"Ru San","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.wnsx.2022.100148_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2021.09.011","article-title":"Risk of intracranial hemorrhage caused by direct oral anticoagulants for stroke prevention in patients with atrial fibrillation (From a network meta-analysis of randomized controlled trials)","volume":"162","author":"Lv","year":"2022","journal-title":"Am J Cardiol"}],"container-title":["World Neurosurgery: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590139722000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590139722000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:22:04Z","timestamp":1762914124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590139722000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":43,"alternative-id":["S2590139722000333"],"URL":"https:\/\/doi.org\/10.1016\/j.wnsx.2022.100148","relation":{},"ISSN":["2590-1397"],"issn-type":[{"value":"2590-1397","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wnsx.2022.100148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100148"}}